The EQUAL study: Utilizing plasma EGFR cfDNA detection as an accessible screening tool for lung cancer in underserved patients ineligible for routine screening.

Authors: Narjust Florez, Lilin Tong, Lauren Kiel, Rebekah Kaufman, Courtney Mantz, Jenna Beckwith, Daniel Botelho Costa, Olayinka Fakorede, Tia Kauffman, Yanan Kuang, Shidong Xu, Alys Malcolm, Shail Maingi, Pedro Manuel Sanz-Altamira, Sapna Syngal, Umit Tapan, Cam Anh Tran, Lecia V. Sequist, Cloud Paweletz, David Allen Barbie

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps3168

Source: Full article


Abstract

TPS3168